← Back to Search

Other

Anti-inflammatory Supplementation for Chronic Pain

N/A

Waitlist Available

Led By Jonathann Kuo, MD

Research Sponsored by Hudson Medical

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants must be 18 years of age or older

At least two (2) or more symptoms of moderate or higher severity musculoskeletal pain for at least one year prior to study enrollment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial studies how a plant-based supplement affects biomarkers of chronic pain in the urine.

Who is the study for?

This trial is for adults over 18 who have been using opioids to manage chronic pain for at least three months and have experienced moderate or severe musculoskeletal pain for a year. It's not open to those under 18, pregnant or breastfeeding individuals, or anyone with a history of recreational opiate use.Check my eligibility

What is being tested?

The study tests the Root.Health dietary supplement's effectiveness in reducing abnormal urine biomarkers linked to chronic pain in patients who regularly use opioids. Participants will take this plant-based supplement daily.See study design

What are the potential side effects?

Potential side effects are not specified here, but as with any dietary supplement, there could be risks of allergic reactions, gastrointestinal discomfort, or interactions with other medications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have had severe joint or muscle pain for over a year.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Effects on Foundation Pain Index (FPI) scores

Secondary outcome measures

Functional Improvements

Pain Improvements

Reduced Opioid Dependency

Trial Design

1Treatment groups

Experimental Treatment

Group I: Daily Supplement TreatmentExperimental Treatment1 Intervention

Following study recruitment and obtaining consent, participants will complete a baseline urine test. The FPI is a simple urine test from Ethos Laboratories that screens for 11 biomarkers that are more likely to contribute to symptoms of pain.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ethos Research & DevelopmentIndustry Sponsor

2 Previous Clinical Trials

105 Total Patients Enrolled

Hudson MedicalLead Sponsor

1 Previous Clinical Trials

Jonathann Kuo, MDPrincipal InvestigatorMedical Director, Hudson Medical

1 Previous Clinical Trials

20 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any additional participants being welcomed into this research program?

"This particular trial is no longer taking on participants, according to clinicaltrials.gov; it was initially posted on June 1st 2023 and last updated a few days later. Nevertheless, there are over one thousand other medical studies actively searching for patients now."

Answered by AI

Could you provide insight into the potential risks of a daily supplement regimen?

"Due to limited information on its efficacy and safety, our team at Power rated Daily Supplement Treatment a 1 out of 3. This is reflective of the fact that it's currently in Phase 1 trials."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Effects of Daily Anti-inflammatory Supplementation on Foundation Pain Index Scores in Chronic Opiate Patients

Jonathann Kuo, MD 2023. "The Effects of Daily Anti-inflammatory Supplementation on Foundation Pain Index Scores in Chronic Opiate Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05896878.